• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Nicholas Robert Explains the Need to Standardize Use of RWE for Measuring Clinical End Points

Video

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses the need for standardizing the use of real-world evidence for measuring endpoints in clinical practice.

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses the need for standardizing the use of real-world evidence for measuring endpoints in clinical practice.

Transcript

How do challenges associated with variation in the use of real-world evidence for measuring endpoints in clinical practice highlight the need for standardization, and are there any potential ways that have been identified to do this?

I think harmonization of results from different groups is absolutely necessary. Friends of Cancer Research actually has provided some leadership. They recently did a study looking at the management of lung cancer using multiple groups. They are now doing a second iteration of that, and we’re happy to say that we’re going to be participating and this will be an opportunity to use common terms and see how much overlap of agreement there is from different data sources.

Related Videos
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Leslie Fish, PharmD.
Adam Colborn, JD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Yuqian Liu, PharmD
Jenny Craven, PharmaD, BCPS
Kimberly Westrich, MA
Sarah Bajorek, PhD, BCACP, MBA.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.